Sodium Hyaluronate Eye Drops

Manufacturer
Guangzhou Hechuang Commercial Service Co.,Ltd.
Effective date
2026-05-11
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:56:53

Label at a glance#

ProductSodium Hyaluronate Eye Drops
Active ingredientSODIUM HYALURONATE
Label structure11 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Sodium Hyaluronate 0.1%

Purpose

OTC - PURPOSE SECTION

Eye lubricant

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water、sodium chloride、Pyridoxine、Cyanocobalamin

INDICATIONS & USAGE SECTION

Used for dry eye syndrome
Relieve dry eye symptoms

•The temporary relief of burning and irritation due to dryness of the eye.
•The temporary relief of discomfort due to minor irritations of the eye or exposure to wind or sun.
•Use as a protectant against further irritation or to relieve dryness of the eye.
•Use as a lubricant to prevent further irritation or to relieve dryness of the eye.

DOSAGE & ADMINISTRATION SECTION

Directions
To open, Twist and pull tab to remove.
•Instill 1 or 2 drops as needed.
•If used for dryness and discomfort associated with LASIK, follow your eye doctor's instructions.

Warnings

WARNINGS SECTION

•For external use only.
•To avoid contamination, do not touch tip of container to any surface.
•Use within 30 days after opening. Maintain good hygiene during use and reseal tightly after each use.
•If solution changes color, do not use.

Stop use and ask a doctor

OTC - STOP USE SECTION

Stop use and ask a doctor.
If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

Other Information

PRECAUTIONS SECTION

•Use only if container is intact.
•Use before expiration date markedon container.
•Store at 59°-86°F (15°-30°C).
•Protect from sunlight.
•Retain this carton for future reference.

REMS ADMINISTRATIVE INFORMATION

Distributed by:Mitsui Pharmaceutical Co., Ltd.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PRINCIPAL DISPLAY PANELPRINCIPAL DISPLAY PANEL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2743151sodium hyaluronate 0.1 % Ophthalmic DropsPSN1
2743151sodium hyaluronate 1 MG/ML Ophthalmic SolutionSCD1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
59361619-24d9-b610-eca6-5a7f25ed5e03Product name520240909
b82b4008-22fd-05f5-6cc6-c0a6e81c65b8Product name220240805
d206bb34-ea65-399d-70d9-834f22dc2c18Product name320170724
5e18e798-5614-cf5c-0185-38b1cb77a093Product name220160822

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87298-037-01Sodium Hyaluronate Eye Drops15 g in 1 BOTTLE, PLASTICLIQUID151

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87298-03787298-037-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sodium Hyaluronate Eye DropsSODIUM HYALURONATEGuangzhou Hechuang Commercial Service Co.,Ltd.5187d136-15c6-517b-e063-6294a90a811d2026-05-11WarningsExact identifier
ndc (package): 87298-037-01
ndc (product): 87298-037
ndc11 (package): 87298003701
spl id: 5187d136-15c7-517b-e063-6294a90a811d
spl set id: 5187d136-15c6-517b-e063-6294a90a811d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.